reSee.it Video Transcript AI Summary
The speaker developed a protocol, BioStrike, and believes it extended Harry Reid's life. In 2015, the speaker petitioned the FDA to use the treatment at diagnosis, hypothesizing that chemotherapy and radiation wipe out natural killer and T cells. The FDA required testing on end-stage patients who had failed standard care.
Despite patients' collapsed immune systems, the speaker reports complete remissions in Merkel cell carcinoma (patient lived six years), bladder cancer (patients alive 10-11 years), triple negative breast cancer, and metastatic pancreatic cancer (patient disease-free after five years, still alive at six). After 700,000 pages of response, the treatment was approved in late 2024. The speaker believes they are on the verge of treating sepsis and cites a recent case of clearing a month-long inflamed lung due to valley fever. The speaker is treating patients with bladder, pancreatic, and lung cancer. The speaker wants to disseminate this information to the scientific, medical, and regulatory communities.